Get the Stockscreener App
1.68
3.45%
-0.06
After Hours:
1.69
0.01
+0.60%
Waldencast Plc stock is traded at $1.68, with a volume of 968.54K.
It is down -3.45% in the last 24 hours and down -9.19% over the past month.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
See More
Previous Close:
$1.74
Open:
$1.75
24h Volume:
968.54K
Relative Volume:
0.78
Market Cap:
$215.48M
Revenue:
$272.07M
Net Income/Loss:
$-248.06M
P/E Ratio:
-0.833
EPS:
-2.0167
Net Cash Flow:
$-16.48M
1W Performance:
+13.51%
1M Performance:
-9.19%
6M Performance:
-1.75%
1Y Performance:
-38.24%
1-Day Range:
$1.60
$1.84
1-Week Range:
$1.45
$1.85
52-Week Range:
$0.72
$3.22
Waldencast Plc Stock (WALD) Company Profile
Name
Waldencast Plc
Sector
Industry
Phone
(917) 546-6828
Address
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, KMB, KVUE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.68 | 225.74M | 272.07M | -248.06M | -16.48M | -2.0167 |
PG
Procter Gamble Co
|
151.41 | 341.47B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
62.48 | 129.46B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
95.13 | 73.36B | 20.80B | 2.22B | 3.77B | 2.5772 |
KMB
Kimberly Clark Corp
|
114.72 | 36.44B | 16.56B | 1.75B | 1.84B | 6.36 |
KVUE
Kenvue Inc
|
19.83 | 36.69B | 15.29B | 1.62B | 1.82B | 0.8433 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-26 | Resumed | Jefferies | Buy |
| Nov-25-25 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| Apr-22-25 | Initiated | Alliance Global Partners | Buy |
| Dec-16-24 | Initiated | TD Cowen | Hold |
| Oct-25-24 | Initiated | Canaccord Genuity | Buy |
| May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Waldencast Plc Stock (WALD) Latest News
Waldencast plc Warrant Financial Disclosures & SEC Filings - TradingView
Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States - Via TT
Price to earnings forward of Waldencast plc – NASDAQ:WALDW - TradingView
Waldencast plc Class A Actuals & Estimates (BOATS:WALD) - TradingView
Price to book forward of Waldencast plc – NASDAQ:WALDW - TradingView
Waldencast PLC (WALDW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Form 13D/A Waldencast plc For: 26 June By Investing.com - Investing.com South Africa
Major Waldencast (WALD) holder reports 0% stake after distributing 9.3M shares - Stock Titan
Waldencast PLC (WALD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Waldencast plc Class A Actuals & Estimates (NASDAQ:WALD) - TradingView
WALD Forecast — Price Target — Prediction for 2027 - TradingView
Form 13G Waldencast plc For: 23 June By Investing.com - Investing.com South Africa
Santa Venerina holds 15M Waldencast shares (WALD) via in‑kind distribution - Stock Titan
Waldencast Company Profile & Introduction - Moomoo
Waldencast PLC (WALDW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waldencast PLC (WALD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Waldencast PLC (WALD) Institutional Confidence - TradingKey
Waldencast PLC (WALD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waldencast PLC (WALD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Waldencast PLC (WALDW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waldencast PLC (WALDW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waldencast PLC (WALD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waldencast PLC (WALDW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Waldencast PLC (WALDW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Waldencast PLC (WALD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Waldencast PLC (WALD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waldencast PLC (WALD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Waldencast PLC (WALDW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Waldencast PLC (WALDW) Institutional Confidence - TradingKey
Waldencast PLC (WALDW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waldencast Delays Warrant Issuance to November as Obagi Wins FDA Nod for saypha ChIQ - The Globe and Mail
FDA approves Obagi saypha ChIQ filler from Waldencast (NASDAQ: WALD) - Stock Titan
Waldencast receives FDA approval for Obagi saypha ChIQ filler By Investing.com - Investing.com Australia
Waldencast receives FDA approval for Obagi saypha ChIQ filler - Investing.com
WALD Q4 2024 Earnings: Significant EPS Miss on Low ExpectationsProfit Margin Analysis - newsline.com
FDA approves Obagi cheek-augmentation filler for midface contour issues - Stock Titan
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel - GlobeNewswire
Waldencast Q4 2024 Earnings: EPS Misses Estimates Amidst Challenging QuarterPost-Earnings Drift - newsline.com
WALD Q4 2024 Earnings: Significant EPS Miss Raises Concerns Amidst Growth StrategyDividend Growth Analysis - newsline.com
Waldencast plc (WALD) Q4 2024 Earnings: Significant EPS Miss Highlights Profitability PressuresShare Dilution Risk - newsline.com
Latham Advises Bridgepoint in Acquisition of Obagi Medical From Waldencast - Latham & Watkins LLP
Canaccord raises Waldencast stock price target on Obagi sale By Investing.com - Investing.com Australia
Canaccord raises Waldencast stock price target on Obagi sale - Investing.com
WALD ALERT: Hagens Berman, National Trial Attorneys, Encourages Waldencast plc (WALD) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations - TMX Newsfile
Obagi Medical sold to Bridgepoint as Waldencast focuses on Milk Makeup brand - FashionNetwork France
Waldencast Announces Sale of Obagi Medical To Bridgepoint - Happi | Household And Personal Products Industry
Waldencast agrees to sell Obagi Medical for up to $460 million By Investing.com - Investing.com India
Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup - TipRanks
Waldencast plc Announces CEO Changes - marketscreener.com
Obagi sale lets Waldencast (NASDAQ: WALD) cut debt and focus Milk - Stock Titan
Waldencast Announces Sale of Obagi Medical to Bridgepoint - The Manila Times
Waldencast Plc Stock (WALD) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.22%
2.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):